Dr. Chloé Kimura

Thoracic medical oncologist · Hôpital Pitié-Salpêtrière · France (FR) · Oncology

Tier 1STK-0014GoodOwner MSL MTMei Tanaka

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC
Scientific interests: PD-L1 biomarkersElderly patientsirAE management
Engagement preference: In person
Advisory boards: 4
Publications: 191
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 1: 4 per year (assumption)

Last engaged: 19 May 2026 (119 days ago)
Next planned contact: 18 Aug 2026 Overdue
Last 6 months vs target: 50%
1 of 2 expected engagements

Insights from this stakeholder (1)

INS-0028Chemotherapy-free first line
08 Feb 2026 · Competitor activity
MediumAction in progress

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
19 May 2026	Payer / HTA meeting	Virtual	Mei Tanaka	Vantrexa	Comparator checkpoint monotherapyChemotherapy-free first line	0	—	Reviewed	ENG-0059
08 Feb 2026	Payer / HTA meeting	Phone	Mei Tanaka	Vantrexa	Chemotherapy-free first line	1	MI request	Reviewed	ENG-0058

Timeline

19 May 2026
Payer / HTA meeting
Comparator checkpoint monotherapy, Chemotherapy-free first line
08 Feb 2026
Payer / HTA meeting
Chemotherapy-free first line

Related stakeholders (6)

Hôpital Pitié-Salpêtrière

Dr. Sven Fischer
Thoracic medical oncologist
Tier 3
Dr. Ulrich Abbott
Pathologist
Tier 1
Dr. Hiroshi Castellano
Pathologist
Tier 3
Dr. Daniel Petit
Pathologist
Tier 1
Dr. Farah Garcia
Pathologist
Tier 3
Dr. Quentin Jensen
Academic nephrologist
Tier 2